Abstract
The worldwide decline in malaria incidence is revealing the extensive burden of non-malarial febrile illness (NMFI), which remains poorly understood and difficult to diagnose. To characterize NMFI in Senegal, we collected venous blood and clinical metadata from febrile patients and healthy controls in a low malaria burden area. Using 16S and unbiased sequencing, we detected viral, bacterial, or eukaryotic pathogens in 29% of NMFI cases. Bacteria were the most common, with relapsing fever Borrelia and spotted fever Rickettsia found in 15% and 3.7% of cases, respectively. Four viral pathogens were found in a total of 7 febrile cases (3.5%). Sequencing also detected undiagnosed Plasmodium, including one putative P. ovale infection. We developed a logistic regression model to distinguish Borrelia from NMFIs with similar presentation based on symptoms and vital signs. These results highlight the challenge and importance of improved diagnostics, especially for Borrelia, to support diagnosis and surveillance.
Competing Interest Statement
P.C.S. is a co-founder of, shareholder in, and consultant to Sherlock Biosciences, Inc. and Delve Bio, as well as a Board member of and shareholder in Danaher Corporation.
Funding Statement
Support for this project was provided in part by the National Institutes of Allergy and Infectious Diseases through the H3Africa and Center for Research in Emerging Infectious Disease programs (U54HG007480, U01HG007480 and U01AI151812 to C.T.H. and P.C.S.), and the Genomic Center for Infectious Disease (U19AI110818 to P.C.S.). Z.C.L was supported by the National Institute of General Medical Sciences (T32GM007753 and T32GM144273). K.J.S received support from the American Society of Tropical Medicine and Hygiene Centennial Award. P.C.S. is an investigator supported by the Howard Hughes Medical Institute (HHMI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences, National Institutes of Allergy and Infectious Diseases, or the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Comité National dEthique de la Recherche en Santé of Senegal gave ethical approval (SEN15/46) for this work. The Harvard University-Area Committee on the Use of Human Subjects gave ethical approval for this work (Protocol number IRB19-0023)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
RNA-mNGS short read sequence data have been deposited in NCBI SRA and Genbank databases under BioProject PRJNA662334 Accession numbers SRR24622550-SRR24622641, SRR24995052-24995258. 16S v1-2 amplicon sequencing data and assembled viral genomes will be deposited shortly under BioProject PRJNA662334, data currently available upon request. The Python source code for the multivariate Borrelia prediction model is available at github.com/colabobio/borrelia-diagnosis-prediction-models.
